The New York Supreme Court is the oldest Supreme Court with general original jurisdiction. It was established as the Supreme Court of Judicature by the Province of New York on . That court was continued by the State of New York after independence was declared in 1776.
For statutes, it is acceptable to just use the section as the short citation as long as it doesn't confuse your reader. For instance, rather than 42 U.S.C. § 1983, you can just use § 1983. For New York, you can use § 120.05 rather than Penal § 120.05.
The mission of the Brooklyn Book Festival (BKBF) is to celebrate published literature and nurture a literary cultural community through programming that cultivates and connects readers of diverse ages and backgrounds with local, national and international authors, publishers and booksellers.
The Manual, also known as "The Tan Book," is what New York judges use when authoring their opinions, so most attorneys use it in lieu of the Bluebook to formulate their citations, even though its use is not mandatory.
Example: N.Y.C. Admin. Code §§ __ - __ (enacted pursuant to N.Y. Tax Law § 111).
For statutes, it is acceptable to just use the section as the short citation as long as it doesn't confuse your reader. For instance, rather than 42 U.S.C. § 1983, you can just use § 1983. For New York, you can use § 120.05 rather than Penal § 120.05.
The main criterion for the inclusion of a product in the Orange Book is that it has an NDA or abbreviated new drug application (ANDA) that has been approved and that has not been withdrawn for safety or effectiveness reasons or determined by FDA to have been withdrawn for safety or effectiveness reasons.
Reference Standard (RS) A “reference standard” is the drug product selected by FDA that an applicant seeking approval of an ANDA must use in conducting an in vivo bioequivalence study required for approval of an ANDA. In the electronic Orange Book, a reference standard is identified by “RS” in the RS column.
The publication Approved Drug Products with Therapeutic Equivalence Evaluations (commonly known as the Orange Book) identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act) and related patent and ...
Patents that are eligible to be listed in the Orange Book are patents that have claims that cover the drug substance (active ingredient), the drug product (formulation and composition), or the approved method of use.